Literature DB >> 7961213

Hospital antibiotic control measures in the UK. Working Party of the British Society for Antimicrobial Chemotherapy.

.   

Abstract

In 1990 374 consultant microbiologists and 733 hospital pharmacists nationwide were sent a questionnaire on methods used to control antibiotic usage. Forty-nine per cent were returned. Attempts to control usage are widespread. A written policy for surgical prophylaxis was available in 51% of hospitals, 62% had a policy for therapy and 79% an antibiotic formulary. The policies for prophylaxis and therapy both gave recommendations on individual drugs in 95% of hospitals, on dosage in 81% and 60% and duration of prophylaxis/treatment in 90% and 51% respectively. Compliance was monitored in approximately 40%, and steps were taken in half to control non-compliance. Eighty-eight per cent believed policies for prophylaxis and therapy to be beneficial. A restricted list was operated in 77% of hospitals and 90% of respondents believed formularies to be beneficial. Fifty-two per cent of respondents claimed educational campaigns were used. These were 'occasional' in frequency in 79% and were most commonly based on information sheets. Fifty per cent of respondents had cost-control campaigns, 26% automatic stop dates on prescriptions and 43% automatic therapeutic substitution. Eleven per cent had antibiotic utilization co-ordinators, 86% of hospitals had a Pharmacy and Therapeutics Committee, and 17% an Antibiotic Committee. Eleven per cent had formal antibiotic audit. Forty-eight per cent of respondents regulated pharmaceutical efforts to promote antibiotics within the hospital. The first survey of current practice suggests that attempts to control antibiotic use are widespread and generally believed to be useful. Several rarely used but potentially helpful control measures, such as specific forms for antibiotic prescriptions, were identified.

Mesh:

Substances:

Year:  1994        PMID: 7961213

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Antimicrobial utilization and bacterial resistance at three different hospitals.

Authors:  V Vlahović-Palcevski; M Morović; G Palcevski; L Betica-Radić
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  An evaluation of quinolone prescribing in a group of acute hospitals: development of an objective measure of usage.

Authors:  C Curtis; R Fitzpatrick; J F Marriott
Journal:  Pharm World Sci       Date:  2002-04

3.  A cross-sectional survey of the profile and activities of Antimicrobial Management Teams in Irish Hospitals.

Authors:  Aoife Fleming; Antonella Tonna; Sile O'Connor; Stephen Byrne; Derek Stewart
Journal:  Int J Clin Pharm       Date:  2014-01-03

Review 4.  The epidemiology of antimicrobial resistance in hospital acquired infections: problems and possible solutions.

Authors:  M J Struelens
Journal:  BMJ       Date:  1998-09-05

Review 5.  Antibacterial use in community practice: assessing quantity, indications and appropriateness, and relationship to the development of antibacterial resistance.

Authors:  A G Carrie; G G Zhanel
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

6.  Encouraging good antimicrobial prescribing practice: a review of antibiotic prescribing policies used in the South East Region of England.

Authors:  P J Wiffen; R T Mayon White
Journal:  BMC Public Health       Date:  2001-05-17       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.